LIQUIDIA CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.53 USD | +1.29% |
|
-5.72% | +4.16% |
| Apr. 01 | Liquidia Says US FDA Cleared to Approve Yutrepia to Treat Hypertension | MT |
| Apr. 01 | Liquidia's Yutrepia Cleared for Potential FDA Approval Following Court Ruling | DJ |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bullish | Bullish |
| Resistance | 14.75 | 16.73 | 16.73 |
| Spread/Res. | -15.05% | -25.10% | -25.10% |
| Spread/Supp. | +1.29% | +26.57% | +26.18% |
| Support | 12.37 | 9.900 | 9.930 |
Technical Rankings Surperformance
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Equities
- LQDA Stock
- Charts Liquidia Corporation
